NuVasive Announces First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
NuVasive (NUVA) PT Raised to $80 at Needham & Company
May 6, 2021 6:58 AM EDTNeedham & Company analyst Mike Matson raised the price target on NuVasive (NASDAQ: NUVA) to $80.00 (from $70.00) while maintaining a Buy rating.
The analyst commented, "NUVA's 1Q21 revenue and EPS beat consensus and revenue growth improved from the prior quarter. Adjusting for comps, we... More
NuVasive (NUVA) Tops Q1 EPS by 2c
May 5, 2021 5:10 PM EDTNuVasive (NASDAQ: NUVA) reported Q1 EPS of $0.37, $0.02 better than the analyst estimate of $0.35. Revenue for the quarter came in at $271.2 million versus the consensus estimate of $261.77 million.
"NuVasive delivered year-over-year growth in the U.S. and international markets, and I am encouraged by the... More
